Výsledky vyhledávání - "de Visser, Adriëtte W"
-
1Hlavní autor Scheper, Henk, Wubbolts, Julia M, Verhagen, Joanne A M, de Visser, Adriëtte W, van der Wal, Robert J P, Visser, Leo G, de Boer, Mark G J, Nibbering, Peter H“…Prosthetic joint infection (PJI) is a severe complication of arthroplasty. Due to biofilm and persister formation current treatment strategies often fail…”
Publikováno v Frontiers in microbiology (29. 01. 2021)
Journal Article -
2Hlavní autor Wieten, Rosanne W, Jonker, Emile F F, van Leeuwen, Ester M M, Remmerswaal, Ester B M, Ten Berge, Ineke J M, de Visser, Adriëtte W, van Genderen, Perry J J, Goorhuis, Abraham, Visser, Leo G, Grobusch, Martin P, de Bree, Godelieve J“…Prompted by recent amendments of Yellow Fever (YF) vaccination guidelines from boost to single vaccination strategy and the paucity of clinical data to support…”
Publikováno v PloS one (15. 03. 2016)
Journal Article -
3Hlavní autor Norrby, Maria, Vesikari, Timo, Lindqvist, Lars, Maeurer, Markus, Ahmed, Raija, Mahdavifar, Shahnaz, Bennett, Sean, McClain, J. Bruce, Shepherd, Barbara M, Li, Daner, Hokey, David A, Kromann, Ingrid, Hoff, Søren T, Andersen, Peter, de Visser, Adriëtte W, Joosten, Simone A, Ottenhoff, Tom H.M, Andersson, Jan, Brighenti, Susanna“…Highlights • H4:IC31 vaccination was well tolerated with an acceptable safety profile. • H4:IC31 vaccination elicited persistent antigen-specific CD4+ T cell…”
Publikováno v Vaccine (14. 03. 2017)
Journal Article -
4Hlavní autor Roukens, Anna H, Soonawala, Darius, Joosten, Simone A, de Visser, Adriëtte W, Jiang, Xiaohong, Dirksen, Kees, de Gruijter, Marjolein, van Dissel, Jaap T, Bredenbeek, Peter J, Visser, Leo G“…Yellow fever vaccination (YF-17D) can cause serious adverse events (SAEs). The mechanism of these SAEs is poorly understood. Older age has been identified as a…”
Publikováno v PloS one (07. 12. 2011)
Journal Article -
5Hlavní autor van Gent, Miriam E, van der Reijden, Tanny J K, Lennard, Patrick R, de Visser, Adriëtte W, Schonkeren-Ravensbergen, Bep, Dolezal, Natasja, Cordfunke, Robert A, Drijfhout, Jan Wouter, Nibbering, Peter H“…Recently, using a deep learning approach, the novel antibiotic halicin was discovered. We compared the antibacterial activities of two novel bactericidal…”
Publikováno v Antibiotics (Basel) (17. 05. 2022)
Journal Article -
6Hlavní autor Roukens, Anna H E, van Halem, Karlijn, de Visser, Adriëtte W, Visser, Leo G“…Outbreaks of yellow fever and a frequently depleted vaccine stock increase demand for a dose-sparing strategy. A fractional dose of 17D yellow fever virus…”
Publikováno v Annals of internal medicine (04. 12. 2018)
Journal Article -
7Hlavní autor van Dissel, Jaap T, Joosten, Simone A, Hoff, Søren T, Soonawala, Darius, Prins, Corine, Hokey, David A, O’Dee, Dawn M, Graves, Andrew, Thierry-Carstensen, Birgit, Andreasen, Lars V, Ruhwald, Morten, de Visser, Adriëtte W, Agger, Else Marie, Ottenhoff, Tom H.M, Kromann, Ingrid, Andersen, Peter“…Highlights•Novel liposome based adjuvant formulation CAF01 safe in first-in-human clinical trial. •H1 antigen + CAF01 adjuvant induce T-cell responses in…”
Publikováno v Vaccine (12. 12. 2014)
Journal Article -
8Hlavní autor Haverkamp, Margje H, van Wengen, Annelies, de Visser, Adriëtte W, van Kralingen, Klaas W, van Dissel, Jaap T, van de Vosse, Esther“…Summary We present a case of pulmonary nontuberculous mycobacterial infection (PNTM) with M. abscessus. After exclusion of genetic immune disorders known to…”
Publikováno v The Journal of infection (01. 06. 2012)
Journal Article -
9Hlavní autor van de Vosse, Esther, de Visser, Adriëtte W., Al-Attar, Sinan, Vossen, Rolf, Ali, Soegianto, van Dissel, Jaap T.“…Background. Enteric fever is defined by circulating Salmonella serotype Typhi or Paratyphi in the blood. The first step in developing enteric fever is…”
Publikováno v Clinical infectious diseases (01. 05. 2010)
Journal Article -
10Hlavní autor Wieten, Rosanne W, Jonker, Emile F.F, Pieren, Daan K.J, Hodiamont, Caspar J, van Thiel, Pieter P.A.M, van Gorp, Eric C.M, de Visser, Adriëtte W, Grobusch, Martin P, Visser, Leo G, Goorhuis, Abraham“…Highlights•The 17 D Yellow Fever vaccination yields an effective immune response in immune-compromised patients. •In measuring post vaccination seroprotection,…”
Publikováno v Vaccine (04. 03. 2016)
Journal Article -
11Hlavní autor Haverkamp, Margje H, Lindeboom, Jerome A, de Visser, Adriëtte W, Kremer, Dennis, Kuijpers, Taco W, van de Vosse, Esther, van Dissel, Jaap T“…Abstract Objective The annual incidence of nontuberculous mycobacterial (NTM) cervicofacial lymphadenitis in otherwise healthy children is unexpectedly high (8…”
Publikováno v International journal of pediatric otorhinolaryngology (01. 07. 2010)
Journal Article -
12Hlavní autor Rosenstein, Mareen D, de Visser, Adriëtte W, Visser, Leo G, Roukens, Anna H E“…Abstract Background In 2013, the World Health Organization (WHO) revised their position on yellow fever vaccination, in which revaccination every 10 years was…”
Publikováno v Journal of travel medicine (29. 12. 2021)
Journal Article -
13Hlavní autor van de Vosse, Esther, Verhard, Els M, Tool, Anton J. T, de Visser, Adriëtte W, Kuijpers, Taco W, Hiemstra, Pieter S, van Dissel, Jaap T“…We have analysed a family with nine congenital neutropenia patients in four generations, several of which we have studied in a long-term follow-up of over 25…”
Publikováno v Annals of hematology (01. 02. 2011)
Journal Article -
14Hlavní autor Sahiratmadja, Edhyana, Wieringa, Frank T., van Crevel, Reinout, de Visser, Adriëtte W., Adnan, Iskandar, Alisjahbana, Bachti, Slagboom, Eline, Marzuki, Sangkot, Ottenhoff, Tom H. M., van de Vosse, Esther, Marx, Joannes J. M.“…Fe-deficiency anaemia is the most common cause of anaemia in developing countries. In these settings, many chronic infections, including tuberculosis (TB), are…”
Publikováno v British journal of nutrition (01. 10. 2007)
Journal Article -
15Hlavní autor Sahiratmadja, Edhyana, Baak-Pablo, Renee, de Visser, Adriëtte W, Alisjahbana, Bachti, Adnan, Iskandar, van Crevel, Reinout, Marzuki, Sangkot, van Dissel, Jaap T, Ottenhoff, Tom H.M, van de Vosse, Esther“…Summary Upon infection with mycobacteria the IL-12/IFN- γ axis plays an essential role in the activation of cell-mediated immunity required for the elimination…”
Publikováno v Tuberculosis (Edinburgh, Scotland) (01. 07. 2007)
Journal Article -
16
-
17Hlavní autor VAN DE VOSSE, Esther, ALI, Soegianto, DE VISSER, Adriëtte W, SURJADI, Charles, WIDJAJA, Suwandhi, VOLLAARD, Albert M, VAN DISSEL, Jaap T“…The cystic fibrosis transmembrane conductance regulator (CFTR) is the affected protein in cystic fibrosis (CF). The high rate of CF carriers has led to…”
Publikováno v Human genetics (01. 11. 2005)
Journal Article -
18Hlavní autor Bühler, Silja, Jaeger, Veronika Katharina, Eperon, Gilles, Furrer, Hansjakob, Fux, Christoph A, Jansen, Stephanie, Neumayr, Andreas, Rochat, Laurence, Schmid, Sabine, Schmidt-Chanasit, Jonas, Staehelin, Cornelia, de Visser, Adriëtte W, Visser, Leonardus G, Niedrig, Matthias, Hatz, Christoph“…Abstract Background More people on immunosuppression live in or wish to travel to yellow fever virus (YFV)-endemic areas. Data on the safety and immunogenicity…”
Publikováno v Journal of travel medicine (26. 09. 2020)
Journal Article -
19Hlavní autor van Dissel, Jaap T, Joosten, Simone A, Hoff, Søren T, Soonawala, Darius, Prins, Corine, Hokey, David A, O'Dee, Dawn M, Graves, Andrew, Thierry-Carstensen, Birgit, Andreasen, Lars V, Ruhwald, Morten, de Visser, Adriëtte W, Agger, Else Marie, Ottenhoff, Tom HM, Kromann, Ingrid, Andersen, Peter“…Here, we report on a first-in-man trial where the tuberculosis (TB) vaccine Ag85B-ESAT-6 (H1) was adjuvanted with escalating doses of a novel liposome adjuvant…”
Publikováno v Vaccine (12. 12. 2014)
Journal Article -
20